Scientists hunt for gut clues to stop cancer Drug's harsh side effect
NCT ID NCT07264985
Summary
This study aims to understand why a common breast cancer drug, pyrotinib, causes severe diarrhea in many patients. Researchers will observe 60 patients already taking the drug, comparing the gut bacteria of those who get diarrhea to those who don't. The goal is to identify specific bacteria that might protect against this side effect, potentially leading to better management strategies in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.